Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Sensorion’s vertigo drug hits tolerability endpoint in phase 2

fiercebiotechDecember 26, 2018

Tag: Sensorion , vertigo drug , tolerability , Meclizine

PharmaSources Customer Service